Human-on-a-chip for Rare Diseases discussion

|

HUMAN-ON-A-CHIP FOR RARE DISEASES DISCUSSION

In our latest publication, UCF & Hesperos researchers discuss how Human-on-a-chip systems can be used to address the unique challenges facing rare diseases. Researchers cite that rare diseases are “limited by the high cost of research and low target population.”

Further Discussion of Human-on-a-chip® technology

Researchers further discuss how “Human-on-a-chip (HoaC) technology, which models human tissues in interconnected in vitro microfluidic devices, has the potential to lower the cost of preclinical studies and increase the rate of drug approval by introducing human phenotypic models early in the drug discovery process.”

Read the publication below:

A human-on-a-chip approach to tackling rare diseasesDownload